Drug major Cipla today said its net profit declined by 22.33% to Rs 214 crore for the fourth quarter ended March 31, 2011, over the same period previous fiscal.
The company had posted a net profit of Rs 275.53 crore in the same period previous fiscal, Cipla said in a filing to the Bombay Stock Exchange (BSE).
Cipla's net sales for the fourth quarter stood at Rs 1,615.22 crore as against Rs 1,317.49 crore for the corresponding period last fiscal.
The company's net profit for the year ended March 31, 2011 stood at Rs 967.12 crore, compared to Rs 1,081.49 crore in the last fiscal.
For the year ended March 31, 2011, the company's net sales stood at Rs 6,123.84 crore, compared to Rs 5,359.52 crore in the previous fiscal.
Shares of Cipla today closed at Rs 303.40 on the BSE, down 1.92% from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app